Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Wymzya Fe(Noreth-Ethinyl Estradiol/Iron)Lupin Limited logoLUPIN.NS

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Lupin Limited

$5,226

Medicare cost, 2024

Medicare drug plans spent $5,226 on Wymzya Fe (noreth-ethinyl estradiol/iron) in 2024, for 48 prescriptions and refills filled by 12 patients. It is made by Lupin Limited (LUPIN.NS).

Medicare cost, 2024

$5,226

-12.2% from 2023

Prescriptions

48

$108.88 per claim

Patients

12

15 prescribers

Total spending, 2024

$5,226

$435.51 per patient

Questions and answers

How much does Medicare spend on Wymzya Fe?

Medicare prescription drug plans paid $5,226 for Wymzya Fe in 2024, for 48 prescriptions and refills to 12 patients (down 12.2% from 2023). The average cost per claim was $108.88.

Who makes Wymzya Fe?

Wymzya Fe is made by Lupin Limited (LUPIN.NS), listed in the Medicare spending data as Lupin Pharmaceu.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Wymzya Fe was $5,226 in 2024, after a high of $40K in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Prescriber data by year

YearPrescribersClaimsPatientsCost
20225516649$15K
2023196317$5,953
2024154812$5,226

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Lupin PharmaceuLUPIN.NS logoLUPIN.NS48$5,226

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube